Dr. Jones and NAF's Published Research

At Apothio Life, our work is grounded in clinical observation, research, and long-term outcomes. Below you’ll find published research, case studies, and downloadable materials related to cannabinoid-based protocols.

CBD for Dravet Syndrome: 10-Year Case Study

This case study follows a pediatric patient diagnosed with Dravet syndrome, a severe form of epilepsy characterized by frequent seizures.

Key Findings

  • Approximately 90% reduction in seizure frequency within two weeks

  • Stabilization to 7–10 mild monthly episodes

  • Discontinuation of pharmaceutical treatments over time

  • No reported adverse side effects

Access the full research and detailed findings:

👉 Download Full Case Study (PDF)
👉 Read Full Breakdown (Blog)

Additional Research

CBD and Dravet Syndrome Research Poster

👉 Download Research Poster (PDF)

Supplemental Case Study Data

👉 Download Supplemental Data (PDF)

We are committed to transparency and continued research. Additional publications and supporting materials will be added here as they become available.

Disclaimer

Apothio Management is NOT a marketing company. Apothio Management is a science-based company focused on safety, toxicology and real consumer outcomes and ultimately reporting those outcomes to our consumers. Apothio Management has not and will not make any health claims and has not been reviewed or approved by the FDA.